1-5 of 5
S de Graaf
Close
Sort by
Journal Articles

Nucleophosmin Gene Mutations Identify a Favorable Risk Group in Childhood Acute Myeloid Leukemia with a Normal Karyotype.

Iris H. Hollink, Christian M. Zwaan, Marry M. van den Heuvel-Eibrink, Martin Zimmerman, Susan Arentsen-Peters, Rob Pieters, Jacqueline Cloos, Gertjan J. Kaspers, Siebold S. De Graaf, Ursula Creutzig, Dirk Reinhardt, Christian Thiede
Journal: Blood
Blood (2007) 110 (11): 366.
https://doi.org/10.1182/blood.V110.11.366.366
Published: 2007
Journal Articles

Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization

D Scandella, M Mattingly, S de Graaf, CA Fulcher
Journal: Blood
Blood (1989) 74 (5): 1618–1626.
https://doi.org/10.1182/blood.V74.5.1618.1618
Published: 1989
Journal Articles

Immunoblot analysis shows changes in factor VIII inhibitor chain specificity in factor VIII inhibitor patients over time

CA Fulcher, K Lechner, S de Graaf Mahoney
Journal: Blood
Blood (1988) 72 (4): 1348–1356.
https://doi.org/10.1182/blood.V72.4.1348.1348
Published: 1988
Journal Articles

FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting

CA Fulcher, S de Graaf Mahoney, TS Zimmerman
Journal: Blood
Blood (1987) 69 (5): 1475–1480.
https://doi.org/10.1182/blood.V69.5.1475.1475
Published: 1987
Journal Articles

Immunologic studies on human factor VIII (anti-hemophilic factor A, AHF) components produced by low-ionic-strength dialysis

BN Bouma, JA van Mourik, S de Graaf, JM Hordijk-Hos, JJ Sixma
Journal: Blood
Blood (1976) 47 (2): 253–264.
https://doi.org/10.1182/blood.V47.2.253.253
Published: 1976